QIAGEN N.V. (QGEN) Stock News
NYSE:QGEN - New York Stock Exchange, Inc. - NL0015002CX3 - Common Stock - Currency: USD
QGEN Latest News, Press Relases and Analysis
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 28.57% and 21.53%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ADPT
Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Sangamo (SGMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: SGMO
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth
Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: ARQT
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts
Investment adviser: 3 signs you're receiving trustworthy trading advice
Red Panda Stock Club founder Ian Dunlap has some suggestions for those trying to decipher exactly who to trust in a landscape where many claim to be experts.
Apetito readies plans for new frozen meals facility in UK
The UK unit of the Germany-based business is building the new site next to existing premises in Trowbridge, Wiltshire.
Bio-Techne Opens New Customer Experience Centre in Germany
TECH announces the opening of a new Customer Experience Centre to support long-term growth in the EMEA region. The new facility is located in Dusseldorf, Germany.
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results
2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62%
Mentions: MTH
QIAGEN delivers solid Q4 2024 growth ahead of outlook
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase
